ClinPhone, the global leader in clinical technology solutions, has made a new appointment to its Group Finance Management Team.
(May 16, 2005) - ClinPhone, the global leader in clinical technology solutions, has made a new appointment to its Group Finance Management Team. Scott Brown has joined the Company in the role of Chief Financial Officer and will be responsible for its overall financial management. Scott will also be tasked with setting financial goals across the Company and ensuring these are measured and reported as appropriate.
Latterly a principal for a consultancy firm specializing in implementation of strategic initiatives, Scott also previously spent five years as Assistant Director for ABN AMRO Corporate Finance, working in both the UK and Hong Kong offices. Scott brings with him a wealth of industry experience and financial knowledge gained from a career spanning 16 years. He will be working closely with the Board of Directors to co-ordinate, monitor and compile detailed, accurate and concise information regarding the Company's operational activity, business opportunity and achievement against business targets.
Scott is a commercially astute and accomplished finance professional with an established record of delivering value in business turnaround and growth situations. He is also a qualified accountant possessing exceptional technical, analytical and management skills with an ability to leverage a range of expertise in strategy, planning, operations and finance.
Steve Kent, Chief Executive Officer at ClinPhone, comments: "With his wealth of experience Scott is a welcome addition to the ClinPhone team, and we feel he will be integral in the Company's continued growth. Scott has an outstanding record dealing with key stakeholders including board level management, major customers and shareholders. He is an extremely motivated and results-orientated individual and we are very excited about the prospective impact of his appointment."
Scott holds a Bachelor of Commerce degree from the University of Western Australia and is an Associate Member of the Institute of Chartered Accountants of Australia. In late 2000 and during 2001 Scott competed in the Times Clipper Round the World Yacht Race, where the high pressure situation helped to hone his management and leadership skills.
For further information on ClinPhone's clinical trial management solutions, please visit www.clinphone.com, or alternatively email info@clinphone.com
About ClinPhone
ClinPhone Group Ltd is a specialist Clinical Technology Organization (CTO) working with the leading global biotech and pharmaceutical organizations. With its corporate headquarters in Nottingham, UK, ClinPhone is the largest and most accomplished CTO with experience in over 1300 clinical trials spanning 88 countries and 71 languages.The company's solutions enable its clients to manage their clinical trials more effectively through the use of technology. Building on its telephone and web-based randomization and medication management expertise, ClinPhone can offer a wide range of innovative products covering all aspects of a clinical trial, including Electronic Patient Reported Outcomes (ePRO), Interactive Voice and Web Response (IVR and IWR), Patient Recruitment Solutions, and Clinical Trial Management Software (CTMS).
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Beyond the Molecule: How Human-Centered Design Unlocks AI's Promise in Pharma
June 23rd 2025How human-centered AI that is focused on customer, user, and employee experience can drive real transformation in clinical trials and beyond by aligning intelligent technologies with the people who use them.
2025 DIA Annual Meeting: Why AI and Automation Are Set to Become the New Normal in Clinical Research
June 20th 2025Peter Ronco, CEO, Emmes, shares his long-term vision for artificial intelligence in clinical research, from making automation routine to improving drug discovery, transforming regulatory oversight, reducing animal testing, and promoting ethical, equitable data use worldwide.